Sonomed Sp. z o.o.
- Address
- lock Available on a paid plan
Digestive System Diseases and Inflammatory Bowel Disease Research at Sonomed Sp. z o.o.
The gastroenterology team in Szczecin is conducting a broad portfolio of studies in digestive system diseases, with a strong focus on ulcerative colitis and Crohn’s disease. These trials are mainly designed to test new therapies, compare treatment options, and improve long-term disease control for people living with inflammatory bowel disease.
- Clinical remission and symptom relief in ulcerative colitis
- Endoscopic and transmural healing in Crohn’s disease
- Evaluation of new biologic and targeted treatments for IBD
Much of the research centers on finding safer and more effective ways to reduce inflammation, improve bowel function, and support durable disease control over time.
Immune System Diseases and Targeted Anti-Inflammatory Therapies
Several studies at this site also address immune system diseases by examining therapies that modulate inflammatory pathways. The main goal is to better understand how newer treatments can reduce immune-driven intestinal inflammation and improve outcomes in chronic conditions such as ulcerative colitis and Crohn’s disease.
- Testing immune-targeted therapies for active ulcerative colitis
- Assessing response and maintenance of benefit in Crohn’s disease
- Exploring improved control of inflammation in immune-mediated disease
This work includes both short-term symptom improvement and longer-term follow-up to see whether new approaches can sustain remission and reduce disease burden.
Nutritional and Metabolic Diseases and Liver Health Studies
The research portfolio extends beyond bowel disorders into nutritional and metabolic diseases, especially alcohol-related liver disease. These trials are focused on evaluating treatments that may improve liver function, reduce damage, and support recovery in patients with chronic liver conditions.
- Evaluating therapies for alcohol-related liver disease
- Measuring changes in liver damage and function
- Studying treatment strategies that may support metabolic and hepatic health
The studies aim to expand options for patients with liver disease by testing whether new interventions can meaningfully improve clinical outcomes.
Hormonal Diseases and Growth-Related Research
Among the site’s broader clinical research efforts are studies in hormonal diseases, including idiopathic growth hormone deficiency in children. This research is centered on understanding the long-term safety and effectiveness of treatments used to support normal growth and development.
- Long-term follow-up in idiopathic growth hormone deficiency
- Monitoring treatment safety in pediatric patients
- Supporting growth-focused care through clinical research
These studies help clarify how hormonal therapies perform over time and whether they can provide sustained benefit for younger patients.
Immune System Phenomena and Celiac Disease Investigation
The site also contributes to research on immune system phenomena, including celiac disease. These trials are designed to examine how immune responses to gluten can be reduced and whether new therapies can improve intestinal health and disease control.
- Assessing immune response in celiac disease
- Studying improvements in intestinal tissue health
- Testing approaches aimed at reducing gluten-triggered inflammation
Overall, this research reflects a strong interest in immune-mediated gastrointestinal disorders and in finding better ways to diagnose, manage, and treat them.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 5 therapeutic areas and 15 of 33 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
- 1Janssen Cilag International4active
lock +9 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International9trials
lock +7 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sonomed Sp. z o.o.
lock Showing 1 of 42 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants with Moderate-to-Severe Active Ulcerative Colitis. | Xencor Inc. | Phase II | Recruiting | Jan 2026 | — |
IMP list
lock Showing 1 of 33 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Duvakitug | 6 | Unknown | 2023-03-17 | 2026-07-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.